Showing results (311-320 of 493) with videos related to

Sort By:
Pageof 50
Clinical and Experimental Immunology|June 1, 1997
Immunomodulatory effects of linomide in animals immunized with immunopathogenic retinal antigens: dissociation between different immune functionsB L Shirkey, S Slavin, B P Vistica, et al.
Experimental Hematology|November 1, 1995
Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitroA Nagler, A Eldor, E Naparstek, et al.
Cancer|October 1, 1992
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantationP E Drakos, A Nagler, R Or, et al.
Bone Marrow Transplantation|April 5, 2005
Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamideM Bitan, R Or, M Y Shapira, et al.
Bone Marrow Transplantation|July 25, 2006
Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?E Hirshfeld, L Weiss, J Kasir, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|April 1, 1994
Entering first-year medical students' attitudes toward managed careM S Wilkes, S A Skootsky, S Slavin, et al.
Bone Marrow Transplantation|December 12, 2002
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?G Hale, S Slavin, J M Goldman, et al.
Diabetologia|December 1, 1994
Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drugD J Gross, H Sidi, L Weiss, et al.
Leukemia Research|October 7, 2008
Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphomaM Har-Noy, M Zeira, L Weiss, et al.
Reviews in Clinical and Experimental Hematology|August 7, 2001
Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disordersS Slavin, A Nagler, M Aker, et al.
Pageof 50